Martín-Cerezuela, María
Aseginolaza-Lizarazu, Maialen
Boronat-García, Patricia
Asensio-Martín, María José
Alamán-Laguarda, Gisela
Álvarez-Lerma, Francisco
Roa-Alonso, David
Socias, Lorenzo
Vera-Artázcoz, Paula
Ramírez-Galleymore, Paula http://orcid.org/0000-0002-7598-3350
Balandin-Moreno, Bárbara
Vidaur-Tello, Loreto
Sánchez-Morcillo, Silvia
Ballesteros-Herráez, Juan Carlos
Ossa-Echeverri, Sergio
Andaluz-Ojeda, David
Blasco-Navalpotro, Miguel Ángel
Abella-Álvarez, Ana
Nogales-Martín, Leonor
Díaz-Santos, Emili
Plans-Galván, Oriol
Conejo-Márquez, Isabel
,
Article History
Received: 17 November 2022
Accepted: 6 February 2023
First Online: 23 February 2023
Declarations
:
: This study was conducted according to the guidelines of the Declaration of Helsinki and approved by The Spanish Agency of Medicines and Medical Devices (AEMPS) (Protocol number UMI-PEN-2019-01). This work was considered as Postauthorization Study with a design other than prospective follow-up (Spanish acronym: EPA-OD). Clinical Research Ethics Committee of the La Fe Hospital reviewed and approved originally the Project and then was approved at each of the participating hospitals. Informed consent was not required due to the research’s method as per the policy of the governmental and local research center.
: Not applicable.
: All authors are members of Infectious Disease Working Group (GTEIS) of the SEMICYUC. The authors declare that they have no conflict of interest.